Enhanced Efficiency of the Basal and Induced Apoptosis Process in Mucopolysaccharidosis IVA and IVB Human Fibroblasts. [PDF]
Brokowska J +3 more
europepmc +1 more source
Consensus statement on enzyme replacement therapy for mucopolysaccharidosis IVA in Central and South-Eastern European countries. [PDF]
Magner M +8 more
europepmc +1 more source
Sex Difference Leads to Differential Gene Expression Patterns and Therapeutic Efficacy in Mucopolysaccharidosis IVA Murine Model Receiving AAV8 Gene Therapy. [PDF]
Piechnik M +11 more
europepmc +1 more source
Clinical features and health-related quality of life in adult patients with mucopolysaccharidosis IVA: the Spanish experience. [PDF]
Quijada-Fraile P +15 more
europepmc +1 more source
Mucopolysaccharidosis (MPS) IVA is a rare lysosomal storage disorder with multiple skeletal and non-skeletal abnormalities requiring multiple surgical interventions.
Seyfullah Gökce +7 more
core +1 more source
Molecular basis of mucopolysaccharidosis IVA (Morquio A syndrome): A review and classification of GALNS gene variants and reporting of 68 novel variants. [PDF]
Zanetti A +17 more
europepmc +1 more source
Early screening for respiratory and cardiac complications in pediatric mucopolysaccharidosis IVA: Insights from a case. [PDF]
Shu H +5 more
europepmc +1 more source
Clinical and molecular spectrum of mucopolysaccharidosis IVA in Iraqi children: Allele-specific genotype-phenotype trends and novel GALNS variants. [PDF]
Wahhab SBA, Thejeal RF.
europepmc +1 more source

